Clinical Trial Update: Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing standard combination ART to dolutegravir monotherapy in patients with primary HIV infection; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome Due to Human Immunodeficiency Virus Infection
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: University of Zurich | Conditions: Monotherapy, Dolutegravir | Phase 2 | Status: UNKNOWN